Israeli company Medigus, which develops minimally invasive medical diagnostic tools, has announced that it has received an $8 million investment. The funds were invested by Israeli healthcare fund OrbiMed Israel Partners, in exchange to ownership of 31 percent of the company.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments